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Background. Klebsiella pneumoniae is a leading cause of extended-spectrum β-lactamase (ESBL)–producing hospital-associ-
ated infections, for which elderly patients are at increased risk.
Methods. We conducted a 1-year prospective cohort study, in which a third of patients admitted to 2 geriatric wards in a specialized 
hospital were recruited and screened for carriage of K. pneumoniae by microbiological culture. Clinical isolates were monitored via the 
hospital laboratory. Colonizing and clinical isolates were subjected to whole-genome sequencing and antimicrobial susceptibility testing.
Results. K. pneumoniae throat carriage prevalence was 4.1%, rectal carriage 10.8%, and ESBL carriage 1.7%, and the incidence 
of K. pneumoniae infection was 1.2%. The isolates were diverse, and most patients were colonized or infected with a unique phylo-
genetic lineage, with no evidence of transmission in the wards. ESBL strains carried blaCTX-M-15 and belonged to clones associated 
with hospital-acquired ESBL infections in other countries (sequence type [ST] 29, ST323, and ST340). One also carried the carbap-
enemase blaIMP-26. Genomic and epidemiological data provided evidence that ESBL strains were acquired in the referring hospital. 
Nanopore sequencing also identified strain-to-strain transmission of a blaCTX-M-15 FIBK/FIIK plasmid in the referring hospital.
Conclusions. The data suggest the major source of K. pneumoniae was the patient’s own gut microbiome, but ESBL strains were 
acquired in the referring hospital. This highlights the importance of the wider hospital network to understanding K. pneumoniae risk 
and infection prevention. Rectal screening for ESBL organisms on admission to geriatric wards could help inform patient manage-
ment and infection control in such facilities.
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Klebsiella pneumoniae is an opportunistic bacterial pathogen 
associated with urinary tract infections (UTIs), pneumonia, 
septicemia, and wound and soft-tissue infections in healthcare 
settings [1]. One of the ESKAPE pathogens, which are collect-
ively responsible for the majority of hard-to-treat infections in 
hospitalized patients [2], K. pneumoniae is frequently multidrug 
resistant (MDR; defined as resistant to ≥3 classes of antibiotics). 
Of particular concern are isolates that produce extended-spec-
trum β-lactamases (ESBLs) or carbapenemases, which confer 
resistance to third-generation cephalosporins and carbapen-
ems, respectively [2]. Among those at risk are infants (who have 
immature immune systems) and the elderly (who have waning 
immune defenses); both are subject to heightened incidence and 
severity of infections [3]. K. pneumoniae, carried asymptomati-
cally in the gastrointestinal (GI) tract, can disseminate to cause 
healthcare-associated infections in at-risk individuals [4, 5]. 
We recently reported a positive association between K. pneu-
moniae GI carriage and age among patients in an intensive care 
unit (ICU) [4]. Older age and hospital stays in geriatric and 
long-term care facilities have previously been linked with MDR 
bacterial colonization and infection [6–8]; hence, geriatric hos-
pital patients can be considered an at-risk group for carriage 
and/or infection with K. pneumoniae. In the current study, we 
aimed to investigate the prevalence, diversity and antimicrobial 
resistance (AMR) of K. pneumoniae carried in the GI and re-
spiratory tracts of patients admitted to 2 geriatric care units.
METHODS
Ethics
Ethical approval for this study was granted by the Alfred 
Hospital (AH) Ethics Committee (project No. 550/12).
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Recruitment and Specimen and Data Collection
Adult patients aged ≥50 years were recruited from 2 geriatric 
medicine wards at the Caulfield Hospital (CH). Verbal consent 
to participate was required from the patient or an adult respon-
sible for them. Rectal and screening swab samples were taken at 
recruitment, usually within the first week of admission to the 
ward. Information on age, sex, dates of hospital and ICU admis-
sion/s, surgery in the last 30 days, and antibiotic treatment in the 
last 7 days were extracted from hospital records and recorded in 
a questionnaire. All clinical isolates recovered from patients at 
CH or the referring hospital (AH) and identified as K.  pneu-
moniae infections by the AH diagnostic laboratory as part of 
routine care were included in the study. See Supplementary 
Methods for further details.
Whole-Genome Sequence Analysis
DNA was extracted and sequenced via Illumina HiSeq. Multilocus 
sequence typing (MLST) was conducted using SRST2 software 
(version 0.2.0) [9]. Single-nucleotide variants (SNVs) were called 
by aligning reads to a reference genome (K. pneumoniae strain 
NTUH-K2044), and used to infer maximum likelihood phylo-
genetic trees. Phylogenetic lineages were defined at a threshold 
of >0.1% divergence. Draft genome assemblies were constructed 
using SPAdes software (version 3.6.1) and used to identify cap-
sule loci with Kaptive software (version 0.4) [10]. Isolates selected 
for finishing (n  =  17) were subjected to long-read sequencing 
with Oxford Nanopore MinION and hybrid assembly of long 
and short reads using Unicycler software (version 0.4.0) [11], as 
described elsewhere [12]. All read sets and finished assemblies 
were deposited in NCBI (accession Nos. in Supplementary Table 
S1). See Supplementary Methods for full details.
AMR and Plasmid Analysis
All clinical and carriage isolates were subjected to antimicro-
bial susceptibility testing using the Vitek2 GNS card and 
Clinical and Laboratory Standards Institute break points. AMR 
genes were identified from Illumina reads using SRST2 (ver-
sion 0.2.0) [9] to screen against the ARG-Annot database [13] 
(Supplementary Table S1). The locations of AMR genes were 
confirmed by BLAST (Basic Local Alignment Search Tool) 
analysis of finished genome sequences, and the Repository of 
Antibiotic Resistance Cassettes database and annotation service 
[14]. Plasmid incompatibility types and subtypes were iden-
tified using PlasmidFinder [15] and established methods for 
IncC subtyping [16, 17].
Statistical Analysis
All statistical analyses were conducted using R software (ver-
sion 3.3.1).
RESULTS
During the 1-year study, 296 adults aged ≥50 years and admit-
ted to 2 geriatric wards of CH (30.5% of 973 patients admitted 
to these wards) were screened for K. pneumoniae carriage via 
rectal and throat swab samples. Participant characteristics are 
given in Table 1. Approximately half (n = 144; 49%) were male, 
and age distributions were similar for both sexes, with a me-
dian age of 84  years (range, 55–102  years). The median time 
of recruitment was day 8 of the current hospital admission 
(range, days 1–83). Of the 296 patients screened, 124 (42%) 
had received antimicrobial therapy in the last 7  days, and 34 
(11%) had undergone ≥1 surgical procedure in the last 30 days 
(Table 1).
Klebsiella Carriage
Isolates identified as K. pneumoniae were cultured from 13.5% 
of participants (Table 1). We estimate the point prevalence of GI 
carriage at 10.8% (95% confidence interval [CI], 7.6%–15.1%) 
and throat carriage at 4.1% (2.2%–7.2%). The carriage rates 
were similar among male and female participants (16% and 
11%, respectively; P = .30 using χ2 test). Carriage was not sig-
nificantly associated with age, sex, or day of admission in lo-
gistic regression models (Supplementary Table S2), although 
the study was underpowered to investigate this conclusively. GI 
carriage of ESBL K. pneumoniae was detected in 5 participants 
(1.7%); 4 of these isolates were also MDR (Table 2).
Table 1. Characteristics of Participants Screened for Klebsiella pneumoniae Carriage
Characteristic Total (n = 296) Male (n = 144) Female (n = 152)
Age, median (range), y 86 (55–102) 85 (55–97) 86 (58–102)
Timing of baseline swab sample, median (range), d of current hospital admissiona 8 (1–83) 7 (1–69) 9 (1–83)
Recent antibiotics, No. (%)b 123 (42) 59 (41) 64 (42)
Recent surgery, No. (%)c 34 (11) 15 (10.4) 19 (12.5)
K. pneumoniae–positive culture, No. (%)
 Rectal swab sample 32 (10.8) 19 (6.3) 13 (8.6)
 Throat swab sample 12 (4.1) 7 (4.9) 5 (3.3)
 Both 4 (1.4) 3 (2.1) 1 (0.7)
aThe day of admission was considered day 1. 
b“Recent antibiotics” was defined as antimicrobial therapy in the last 7 days before screening. 
c“Recent surgery” was defined a surgical procedures of any kind in the last 30 days before screening.
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K. pneumoniae Infections
Twelve (1.2%) of the CH study ward patients (7 female, 5 male) 
had K.  pneumoniae infections diagnosed (all UTIs). Patient 
characteristics are shown in Table 3. The K. pneumoniae UTI 
rate was very low in noncarriers (0.76%; 2 of 264), however, 
the numbers are too small for meaningful comparisons with 
the rate in carriers (1 of 32; 3%; note that 9 UTIs occurred in 
patients not screened). Four of the 14 UTI isolates (from 12 
patients) were MDR, and 3 produced ESBLs (Table 3).
Genomic Diversity of Klebsiella
We sequenced the genomes of all 59 isolates identified as 
K.  pneumoniae from patients in the study wards: 12 throat 
swab sample, 33 rectal swab sample, and 14 UTI isolates, orig-
inating from 53 patients. Five carriage isolate genomes were 
excluded from detailed phylogenetic analysis owing to sequence 
failure (n = 1) or mixed culture (n = 4). Genome data from the 
remaining 54 isolates confirmed they were members of the 
K. pneumoniae complex, which are typically indistinguishable 
biochemically [18]: 37 K. pneumoniae, 2 Klebsiella quasipneu-
moniae, 15 Klebsiella variicola (Figure 1). UTI isolates were pre-
dominantly K. pneumoniae (n = 12/14, 86%). Carriage isolates 
were more diverse, with only 63% K. pneumoniae, but the dif-
ference was not statistically significant (P = .20 using χ2 test).
A core genome tree of the 54 Klebsiella isolates (Figure  1) 
showed they represent a diverse population comprising 45 
phylogenetically distinct lineages. These included some com-
mon MLST sequence types (STs) previously associated with 
AMR infections in hospitals (ST17, ST20, and ST340) [19] or 
severe community-acquired infections (ST23 and ST45) [18, 
20], as well as 13 novel STs that were submitted to the MLST 
database for ST assignment (5 K. pneumoniae and 8 K. varii-
cola). Thirty-seven distinct capsule locus types were also 
detected [10] (Figure 1 and Supplementary Table S1).
Table 2. Details of Participants With Rectal Screening Swab Samples Positive for Extended-Spectrum β-Lactamase Klebsiella pneumoniae 
Patient Age, y Sex Recent Surgerya Recent Antibioticsb Isolatec Antimicrobials to Which Resistance Was Detectedd
CH0031 96 M No Cro KSB1_1B Kz, Cro
CH0138 91 F Yes Tmp KSB1_9D Amc, Tim, Tzp, Kz, Caz, Cro, Gen, Tob, Cip, Nor, Tmp, Sxt
CH0142 72 M No … KSB1_4E Tim, Tzp, Kz, Fox, Caz, Cro, Tob, Cip, Tmp, Sxt
CH0260 72 F No Amc KSB1_10J Kz, Cro, Tmp, Sxt
CH0274 73 F No Van, Cip, Cfx KSB2_1B Kz, Cro, Tmp, Sxt
Abbreviations: Amc, amoxicillin–clavulanic acid; Caz, ceftazidime; Cfx, cefuroxime; Cip, ciprofloxacin; Cro, ceftriaxone; F, female; Fox, cefoxitin; Gen, gentamicin; Kz, cefazolin; M, male; Nor, 
norfloxacin; Sxt, trimethoprim-sulfamethoxazole; Tim, ticarcillin–clavulanic acid; Tmp, trimethoprim; Tob, tobramycin; Tzp, tazobactam-piperacillin; Van, vancomycin. 
a“Recent surgery” indicates surgery of any kind in the last 30 days before screening. 
b“Recent antibiotics” were defined as antibiotic treatment in the last 7 days before screening. 
cCH0031 isolate KSB1_1B carried blaCTX-M-55; the others carried blaCTX-M-15. 
dAntimicrobial resistance phenotyping was conducted using Vitek2 software and interpreted using Clinical and Laboratory Standards Institute thresholds. All isolates were confirmed re-
sistant to ampicillin. Additional drugs to which acquired resistance was detected are listed. All 5 isolates were susceptible to cefepime, meropenem, and amikacin.
Table 3. Details of Klebsiella pneumoniae Urinary Tract Infectionsa 
Patient Age, y Sex Carriage Positive Antimicrobials to Which Clinical Isolate Displayed Resistanceb
CH0110 92 F No Isolate 1: …
Isolate 2: Tmp and Sxt
CH0138 91 F Yes Isolate 1: Amc, Tim, Tzp, Kz, Caz, Cro,c Gen, Tob, Cip, Nor, Tmp, Sxt
Isolate 2: Amc, Tim, Tzp, Kz, Caz, Cro,c Gen, Tob, Cip, Nor, Tmp, Sxt, Fox, Fep, Mer
CH0258 91 F No Amc, Tim, Kz, Caz, Cro,c Tob, Tmp, Sxt
KC0049 78 F NP …
KC0061 90 F NP …
KC0109 69 M NP …
KC0191 91 M NP Amc, Tim, Tzp, Kz, Cro,c Fep, Tob, Tmp, Sxt
KC0216 86 M NP Nor
KC0302 81 M NP …
KC0303 71 M NP …
Where two clinical isolates were cultured, these are labelled 1 and 2, and antimicrobial resistance phenotypes are given for both.
Abbreviations: Amc, amoxicillin–clavulanic acid; Ami, amikacin; Caz, ceftazidime; Cip, ciprofloxacin; Cro, ceftriaxone; F, female; Fep, cefepime; Fox, cefoxitin; Gen, gentamicin; Kz, 
cefazolin; M, male; Mer, meropenem; Nor, norfloxacin; NP, not participating; Sxt, trimethoprim-sulfamethoxazole; Tim, ticarcillin–clavulanic acid; Tmp, trimethoprim; Tob, tobramycin; Tzp, 
tazobactam-piperacillin.
aCharacteristics of patients and corresponding urine isolates are provided. Carriage screening swab sample results are given for patients who were also recruited as participants in the 
carriage study. 
bAntimicrobial resistance phenotyping was conducted using Vitek2 software and interpreted using Clinical and Laboratory Standards Institute thresholds. All isolates were confirmed re-
sistant to ampicillin. Additional drugs displaying acquired resistance are listed. 
cIsolate identified as extended-spectrum β-lactamase producer.
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Of the 4 individuals with both rectal and throat isolates, 3 were 
colonized with different strains at each site (Figure 1). All K. qua-
sipneumoniae and K. variicola isolates were singleton strains; that 
is, each represented a unique lineage detected in a single patient. In 
contrast, 3 K. pneumoniae lineages were identified in ≥2 patients 
and thus could potentially indicate transmission in CH (ST323, 
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Figure 1. Core genome phylogeny for Klebsiella isolated from patients in the study wards, indicating multi-locus sequence typing (MLST) and capsule locus (KL) genotypes, 
and antimicrobial resistance (AMR) phenotypes. The tree is a maximum-likelihood phylogeny inferred from 489 069 single-nucleotide variants in 3769 core genes; all branches 
defining species or lineages (ie, clades of isolates sharing sequence types from MLST) have >90% bootstrap support. Scale bar indicates nucleotide divergence. Clusters of 
genomes with patristic distance ≤0.1% nucleotide divergence are highlighted. Curved lines indicate isolates from the same patient (green, carriage isolates; purple, infection 
isolates; black, carriage and infection isolates). K loci were identified using Kaptive software. AMR phenotypes, determined using Vitek2 and interpreted according to Clinical 
and Laboratory Standards Institute guidelines, are indicated in the heat map and colored by drug class according to the inset legend; Asterisks denote multidrug resistance 
(resistant to ≥3 drug classes). Amc, amoxicillin–clavulanic acid; Ami, amikacin; Amp, ampicillin; Caz, ceftazidime; Cip, ciprofloxacin; Cro, ceftriaxone; Fep, cefepime; Fox, 
cefoxitin; Gen, gentamicin; Kz, cefazolin; Mer, meropenem; Nor, norfloxacin; Sxt, trimethoprim-sulfamethoxazole; Tim, ticarcillin–clavulanic acid; Tmp, trimethoprim; Tob, 
tobramycin; Tzp, tazobactam-piperacillin.
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ST29, and ST37; dark shading in Figure 1). To investigate further, 
we used long-read sequencing to generate high-quality, com-
pletely resolved genome sequences for these isolates (Methods 
and Supplementary Table S3), and we calculated SNV distances 
between isolates within each cluster (Table 4). The ST37 isolates 
were separated by 1816 SNVs (433 mutations plus 1383 SNVs 
introduced by recombination; Supplementary Figure S1) and 
thus represent independent strains not linked by recent trans-
mission. The ST323 and ST29 isolates were much more closely 
related (4–40 SNVs), consistent with recent transmission. These 
isolates were ESBL and are investigated in detail below.
MDR Mechanisms and Transmission
Seven of the 54 isolates were MDR (Figure 1). These belonged to 
the 2 potential transmission clusters (ST29 and ST323) and UTI 
and colonizing isolates from patient CH0138 (ST340). To inves-
tigate the genetic mechanisms for resistance, we used long-read 
sequencing to completely resolve these genomes (Methods). 
The ST29 and ST323 MDR isolates each harbored 4–6 plasmids 
(Supplementary Table S3). Notably, all the acquired AMR genes in 
these genomes were localized to the same >200–kilobase pair FIBK/
FIIK plasmid backbone encoded conjugative transfer functions. 
This shared close similarity (>90% coverage and 99% identity) with 
plasmid pKPN3-307_type A from an Italian K. pneumoniae [21]. 
However there were some differences in the MDR regions, result-
ing in different susceptibility profiles (Supplementary Figure S2).
Both CH ST29 UTI isolates displayed similar AMR profiles 
and harbored the same set of 12 AMR genes, including the ESBL 
gene blaCTX-M-15 (Supplementary Figure S2). In 1 of the ST29 iso-
lates, INF322, the AMR genes were located on a 243 634–base 
pair circular plasmid (pINF322), carrying the FIBK and FIIK 
replicons. This entire plasmid sequence was integrated into 
the chromosome of INF249, within a 23S ribosomal RNA gene 
(Supplementary Figure S2A), flanked by copies of IS26 and an 
8–base pair target site duplication (GGCTTTTC). The pINF322 
plasmid carried 8 copies of IS26, and the integration event in 
INF249 seems to have been mediated by the copy situated 
next to the aac6-Ib gene (Supplementary Figure S2A). The first 
ST323 carriage isolates, KSB1_4E, carried a plasmid sequence 
(pKSB1_4E) that differed from pINF322 by just 1 SNV. Two of 
the other 3 ST323 isolates carried the identical plasmid back-
bone to pKSB1_4E (no SNVs). All 3 harbored blaCTX-M-15 within 
a variable MDR region (Supplementary Figure S2B).
We investigated transmission of ST29 and ST323 strains and 
plasmids based on SNV counts, phylogenetic relationships, and 
hospital admission data (including time in CH and the referring 
hospital AH). In both the ST29 and ST323 clusters, the data did 
not support direct transmission between the patients in CH, be-
cause in many cases they lacked overlapping time in the wards 
(Figure 2A). Given the close genetic distances between isolates 
(4–40 SNVs, Table 4), we hypothesized that they may be linked 
by transmission in the referring hospital rather than CH. To in-
vestigate this we analyzed all ST29 and ST323 clinical isolates 
identified at AH and CH during the study period, and we con-
structed core genome phylogenies (Figure  2B). The CH ST29 
isolates belonged to a group of 12 closely related strains (iso-
lated in the last 4 months of the study) that shared a common 
ancestor with AH isolates, from which each differed by 1–4 
SNVs (Figure 2B). Similarly, the CH ST323 isolates belonged to 
a group of 27 strains (isolated throughout the study) that shared 
a common ancestor with AH isolates, from which each differed 
by between 3 (early isolates) and 34 SNVs (late isolates).
All ST29 isolates and n = 26/27 ST323 isolates shared the same 
FIBK/FIIK plasmid sequence, separated by ≤1 SNV in the back-
bone sequence (note it is possible the remaining ST323 isolate 
also had the plasmid but lost it in culture). There was variation 
Table 4. Pairwise Genetic Differences Between Isolates in Multipatient Lineagesa 
Patient ID by ST Age, y Sex Sample ID Specimen Sample Date (dd/mm/yyyy)
SNVs, No.
Chromosome FIBK/FIIK Plasmid
ST29
 KC0191 91 M INF249 UTI 01/12/2013 … …
 CH0258 91 F INF322 UTI 17/02/2014 4 39b
ST323
 CH0142 72 M KSB1_4E Rectal 10/09/2013 … …
 CH0150 85 M KSB1_7E Rectal 17/09/2013 4 NA
 CH0260 72 F KSB1_10J Rectal 11/02/2014 19 0
 CH0274 73 F KSB2_1B Rectal 25/02/2014 40 5
ST37 (KL14)
 CH0110 92 F INF042 UTI 08/05/2013 … …
 CH0110 92 F INF059 UTI 16/05/2013 4 NA
 CH0252 85 M KSB1_7J Rectal 04/02/2014 1786 NA
Abbreviations: F, female; ID, identifier, M, male; NA, not available (no FIBK/FIIK sequence detected); SNVs, single-nucleotide variants; ST, sequence type; UTI, urinary tract infection.
aEach isolate within a lineage is listed with accompanying patient and sample data, as well as the number of chromosomal and plasmid SNVs detected between the isolate and the first 
collected isolate from the same lineage. 
bIn INF249, the FIBK/FIIK plasmid sequence is integrated into the chromosome.
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Collection
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Negative swab sample
Positive swab sample
CH (study ward) 
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CH (other ward)
Figure 2. Multidrug-resistant extended-spectrum β-lactamase producing lineages associated with multiple patients in the study wards. A, Timelines for Caulfield Hospital 
(CH) and Alfred Hospital (AH) stays for patients in the CH study wards who were infected with sequence type (ST) 29 or colonized with ST323 Klebsiella pneumoniae. Details 
of all admissions to CH (study site) or AH (referring hospital) during the 1-year study period (1 April 2013 to 31 March 2014) were extracted from the hospital records of 
these patients. (Note that CH0274 and CH0142 short-term stays are all AH, not intensive care unit [ICU] or CH.) ID, identifier. B, Midpoint-rooted core genome phylogenetic 
trees for all ST29 and ST323 K. pneumoniae isolated at CH or AH during the study period. Tips are colored by hospital of corresponding specimen collection, according to 
inset legend. Isolates from the CH study wards are highlighted in gray. Branches are labeled with the number of chromosomal single-nucleotide variants (SNVs) defining the 
branch (black numbers, above branch) and the number of SNVs in the corresponding FIBK/FIIK plasmid sequence, relative to the major genotype (red numbers, below branch; 
see Supplementary Figure S2 for plasmid tree; ∆, plasmid lost; chr, plasmid integrated into chromosome). Dates of isolation are given in dd/mm/yyyy format. Antimicrobial 
resistance (AMR) phenotypes, determined using Vitek2 and interpreted according to Clinical and Laboratory Standards Institute guidelines, are indicated in the heat map 
and colored by drug class according to inset legend. Amc, amoxicillin–clavulanic acid; Ami, amikacin; Amp, ampicillin; Caz, ceftazidime; Cip, ciprofloxacin; Cro, ceftriaxone; 
Fep, cefepime; Fox, cefoxitin; Gen, gentamicin; Kz, cefazolin; Mer, meropenem; Nor, norfloxacin; Sxt, trimethoprim-sulfamethoxazole; Tim, ticarcillin–clavulanic acid; Tmp, 
trimethoprim; Tob, tobramycin; Tzp, tazobactam-piperacillin. 
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in the MDR regions, resulting in variable AMR phenotypes 
(Figure 2B and Supplementary Figure S2C), but blaCTX-M-15 was 
retained in all but 2 isolates.
Carbapenem Resistance
Meropenem-resistant K.  pneumoniae was detected in 1 CH 
patient (CH0138). Their rectal carriage isolate and 2 clinical 
urine isolates, collected on the same day, shared near-identical 
chromosomal sequences separated by a single SNV (Figure 3). 
Patient CH0138 was discharged after 2 months and readmitted 
to AH nearly 2 months later. K. pneumoniae was isolated from 
clinical urine samples on days 4 and 10 of the second admission. 
These were also ST340, separated from the earlier isolates by 
3–5 SNVs (Figure 3).
AH
CH (study ward)
CH (other ward)
Colletion
date
AH ward ICU
CH (study ward)
CH (other ward)
AH
External nursing home
Positive swab sample 
β
Figure 3. Carbapenemase producing lineage sequence type (ST) 340. A, Core genome phylogenetic tree of all ST340 isolates identified at Caulfield Hospital (CH) or Alfred 
Hospital (AH) during the study period. Branches are labeled with number of chromosomal single-nucleotide variants (SNVs). CSF, cerebrospinal fluid. Dates of isolation are 
given in dd/mm/yyyy format. Antimicrobial resistance (AMR) phenotypes, determined using Vitek2 and interpreted according to Clinical and Laboratory Standards Institute 
guidelines, are indicated in the heat map and colored by drug class according to inset legend. Amc, amoxicillin–clavulanic acid; Ami, amikacin; Amp, Ampicillin; Caz, ceftazi-
dime; Cip, ciprofloxacin; Cro, ceftriaxone; Fep, cefepime; Fox, cefoxitin; Gen, gentamicin; Kz, cefazolin; Mer, meropenem; Nor, norfloxacin; Sxt, trimethoprim-sulfamethoxazole; 
Tim, ticarcillin-clavulanic acid; Tmp, trimethoprim; Tob, tobramycin; Tzp, tazobactam-piperacillin; B, Timelines for hospital stays; all admissions to CH (where study wards 
were located) or AH (referring hospital) during the 1-year study period (1 April 2013 to 31 March 2014) were extracted from hospital records of these patients. ICU, intensive 
care unit. C, Comparison of AMR regions in the 2 forms of IncC plasmid identified in these isolates; AMR genes and mobile elements genes are labeled and colored according 
to the inset legend; white arrows indicate genes of other or unknown functions. CP, carbapenemase producing, defined by presence of blaIMP-4 gene and phenotypic mero-
penem resistance (Mer in A); ESBLs, extended-spectrum β-lactamases.
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Two distinct AMR patterns were observed among the 
CH0138 isolates: all were ESBL and MDR, however the first 
and last urine isolates were also resistant to cefoxitin, cefepime, 
and meropenem (Figure 3A). Completion of the genomes with 
long reads showed the MDR phenotypes were conferred by (1) 
chromosomal insertions of sul1, aadA2 (via a type 1 integron) 
and blaCTX-M-15 (via ISEcp1); (2) 2 large conjugative plasmids: a 
novel 90–kilo–base pair plasmid sharing 2 replicon genes (repB 
and repE) with pK245 (accession No. DQ449578), carrying 
aac3-IIa, aac6Ib-cr, catB4, strAB, blaOXA-1, sul2 and qnrB1; and 
an IncC type 2 plasmid [16] (also known as IncA/C2 plasmid 
sequence type 3 [17]) carrying blaTEM, aadA2, tetA, dfrA14 
(Figure 3C and Supplementary Table S4). In the meropenem-re-
sistant strains, the IncC plasmid also carried the carbapenemase 
blaIMP-26 as well as mphA, aac3-IIa, and catB3 (Figure 3C).
Comparison with clinical isolates identified in AH during 
the study period identified 4 additional ST340 isolates from 2 
patients, which shared the same plasmids and chromosomal 
AMR determinants and were separated from the first CH0138 
isolate by 2–5 chromosomal SNVs (Figure 3A, Supplementary 
Table S4). Three strains (blood, cerebrospinal fluid, and rectal 
swab sample isolates) were isolated from patient AH0095 on 
admission to the ICU with sepsis. This followed a month-long 
stay in AH, which overlapped with the AH admissions of the 
other 2 patients, probably providing the opportunity for trans-
mission (Figure 3B).
DISCUSSION
We estimated overall carriage prevalence in the first week of ad-
mission to the geriatric unit at 13.5%, with 10.8% GI carriage 
and 4% throat carriage. GI carriage prevalence was significantly 
higher than we estimated previously for patients admitted to 
the AH ICU with no recent healthcare exposure [4] (5.9%; 
odds ratio [OR], 1.94 [95% CI, 1.0–3.7]; P  =  .03) but signifi-
cantly lower than for ICU patients who had been in the hospital 
for >2  days or had undergone recent surgery (19%; OR 0.52 
[0.3–0.9]; P =  .02). The rate was also lower than that recently 
estimated for ICU and hematology/oncology patients at a US 
hospital [5] (23%; OR, 0.41 [95% CI, .27–.60]; P < .001).
Colonizing isolates were diverse (Figure 1) and mostly unique 
to individual participants, consistent with our earlier observa-
tions in ICU patients [4] and the recent US study [5]. Hence, in 
most cases, these strains probably represent established mem-
bers of the patients’ microbiota rather than hospital-acquired 
bacteria. In the ICU, K.  pneumoniae carriage is significantly 
associated with subsequent infection (OR, ≥4) [4, 5]. In the 
current setting, K. pneumoniae infections occurred at a similar 
rate (1.2% vs 1.8%–2.2%: P > .1) but the number of cases was 
too small to explore directly the link between colonization and 
infection. Notably, the 12 patients with K.  pneumoniae infec-
tions were infected with 11 different lineages, consistent with 
most patients developing a UTI from their own microbiota. The 
exceptions were 2 UTIs associated with ESBL ST29, acquired by 
both patients in the referring hospital (Figure 2).
ESBL carriage (1.7%) was much more rare than previ-
ously reported in point prevalence studies of geriatric units or 
long-term care facilities [22, 23]. This is unsurprising, because 
we aimed to screen patients during the first week of their CH 
stay and focused only on K. pneumoniae. The MDR strains iden-
tified at CH all belonged to lineages that have been previously 
associated with hospital outbreaks of ESBL and/or carbapen-
emase-producing (CP) K.  pneumoniae on other continents 
(ST29, ST323, and ST340) [24, 25], indicating the emergence 
of globally distributed ESBL strains in Australia. The ST258 
strains harboring the K.  pneumoniae carbapenemase, which 
are common internationally, have also been recently detected 
in Australia [26]. FIBK/FIIK plasmids are frequently reported as 
disseminators of blaCTX-M-15 and other AMR genes in K. pneu-
moniae, Escherichia coli, and other enteric bacteria isolated 
from humans, animals, and the environment [27, 28]. The IncC 
plasmid carrying blaIMP was recently reported in K. pneumoniae 
(ST unknown) isolated from Australian wild birds [29], indicat-
ing that this plasmid and possibly the host strain are involved in 
spreading carbapenemases between animals and humans.
This study employed Illumina short-read whole-genome 
sequencing to identify high-confidence SNVs with which 
to identify lineages and AMR genes, bolstered by long-read 
sequencing to resolve plasmids and AMR gene context and 
maximize resolution for detecting transmission. Although this 
strategy has been used in other studies [30–33], ours is the first 
to adopt multiplex nanopore sequencing and hybrid assembly 
to rapidly and cost-efficiently complete genome sequences of 
interest in a high-throughput manner [11, 12] (Supplementary 
Tables S3 and S4). However, unravelling the source of MDR 
K.  pneumoniae in CH also required exploring patient move-
ment before CH admission, and phylogenetic context provided 
by additional isolates from the referring hospital.
Our analyses revealed that all MDR K. pneumoniae isolated at 
CH were linked to transmission clusters at the referring hospital 
(Figures 2 and 3). This suggests that MDR carriage is rare in the 
community, but MDR ESBL K. pneumoniae were occasionally 
acquired in the referring hospital before transfer to CH (ESBL 
GI carriage prevalence, 1.7%; ESBL infection incidence, 0.31%). 
These findings are likely generalizable to other hospital referral 
networks and highlight the benefits of exploring transmission 
at a multifacility level [34, 35]. However, larger studies will be 
needed to confirm the importance of referral networks for trans-
mission of ESBL organisms, as has been demonstrated for MRSA 
and Clostridium difficile [34, 35], and to explore specific risk fac-
tors and the relevance to healthcare-associated infections.
It is noteworthy that the 2 ESBL lineages transmitting at AH 
(ST323 and ST29) shared the same FIIK/FIBK blaCTX-M-15 plasmid. 
Given that ST323 seems to have been circulating at AH for 
months before the common ancestor of the ST29 strains, we 
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hypothesize that the plasmid transferred from ST323 to ST29 
within the hospital, promoting transmission of ST29 within AH. 
This highlights the importance of tracking ESBL or CP plasmids, 
as well as their host strains, as noted elsewhere [30, 31, 36].
The spread of CP K.  pneumoniae within the referring hos-
pital is concerning. The CP ST340 strain carrying blaIMP and 
blaCTX-M-15 was identified in clinical isolates from 2 patients (pa-
tient AH0095, isolates KSB1_5D, INF157, and INF158; patient 
CH0138, isolate INF164). Additional variants lacking blaIMP 
were found in 1 of these patients (patient CH0138) along with 
an ST340 UTI isolate from a third patient (patient AK0142) 
(Figure  3). Notably, the ST340 strain was detected on rectal 
swab samples from both patients who were screened for car-
riage (1 CH patient in this study; 1 ICU patient in the prior 
study [4]). However, it is encouraging to note that we detected 
no evidence of its transmission within the CH wards.
Only one-third of CH patients were recruited for GI carriage 
screening. Although 2 of the 3 patients with MDR infection were 
not screened, given the strong evidence that they acquired their 
infecting strain (ESBL ST29) in the referring hospital (Figure 2), 
it is possible they would have been detected as ESBL carriers if 
swab samples had been obtained on their arrival. Surveillance 
swab samples are frequently recommended to screen for car-
riage of MDR organisms in a variety of settings [37–39], but 
their role in the management of ESBL or CP gram-negative 
infections outside of outbreaks remains controversial [40]. Our 
study findings suggest that screening on transfer from tertiary 
referral hospitals to specialized hospitals could be valuable for 
the management or prevention of MDR infections.
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